cefpiramide and Urinary-Bladder-Neoplasms

cefpiramide has been researched along with Urinary-Bladder-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for cefpiramide and Urinary-Bladder-Neoplasms

ArticleYear
[Clinical studies on Suncefal (cefpiramide) concentration in prostatic tissue and bladder wall].
    Hinyokika kiyo. Acta urologica Japonica, 1988, Volume: 34, Issue:3

    The cefpiramide (CPM) concentration in prostatic tissue of 19 patients with benign prostatic hypertrophy and bladder wall of 2 patients with bladder tumors was measured, after 2 g of CPM was administered intravenously by bolus technique prior to operation. Prostatic tissue level was 28.4 to 131 micrograms/g and tissue to serum ratio 0.15 to 0.63 at 12 min. to 220 min. after administration. The T1/2 of CPM in prostatic tissue was 3.29 hours. The bladder wall level was high at both determinations. CPM level in prostatic tissue and bladder wall covered the minimum inhibitory concentration of many bacteria detected from the infected sites. Therefore, CPM which has a strong antimicrobial activity can be considered as a highly useful antibiotic for the treatment of postoperative infections.

    Topics: Aged; Aged, 80 and over; Bacterial Infections; Cephalosporins; Humans; Male; Middle Aged; Postoperative Complications; Prostate; Prostatic Hyperplasia; Tissue Distribution; Urinary Bladder; Urinary Bladder Neoplasms

1988